Back
abrdn Life Sciences Investors 10K Form
Sell
29
HQL
abrdn Life Sciences Investors
Last Price:
14.78
Seasonality Move:
6.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HQL News And Ratings
See the #1 stock for the next 7 days that we like better than HQL
HQL Financial Statistics
Sales & Book Value
Annual Sales: | $124.08M |
---|---|
Cash Flow: | $0 |
Price / Cash Flow: | 0 |
Annual Sales: | $0.00 |
Price / Book: | 0 |
Profitability
Net Income (TTM): | $0 |
---|---|
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
abrdn Life Sciences Investors Earnings Forecast
Key abrdn Life Sciences Investors Financial Ratios
- Per Share Earnings over the last 4 years have been positive in 1 years.
abrdn Life Sciences Investors Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Current Symbol: | HQL |
CUSIP: | 87911K |
Website: | abrdnhql.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
HQL Technical Analysis vs Fundamental Analysis
Sell
29
abrdn Life Sciences Investors (HQL)
is a Sell
Is abrdn Life Sciences Investors a Buy or a Sell?
-
abrdn Life Sciences Investors stock is rated a Sell
The current abrdn Life Sciences Investors [HQL] share price is $14.71. The Score for HQL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.